Trial intelligence / Profile preview

EARLY-MYO in STEMI

NCT01930682Phase 4Completed

Sponsor
Renji Hospital
Start
Jan 2014
Primary completion
Sep 2016
Modality
rProtein (Recombinant Protein), Biologic
Countries
1
01

Overview

A Phase 4 trial of tissue-plasminogen activator in ST elevation myocardial infarction (STEMI), sponsored by Renji Hospital. Started Jan 2014; status: completed.

02

Drugs

tissue-plasminogen activator
03

Conditions

ST elevation myocardial infarction (STEMI)

Beyond the preview

Go deeper on NCT01930682.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01930682.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call